Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04635579 · ClinicalTrials.gov registry record · NA

Personalized Blood Flow Restriction for Anterior Cruciate Ligament Rehabilitation

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT04635579 is a NA study that has completed, run by University of Washington. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04635579, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

This is a cross-sectional study on the use of personalized blood flow restriction during rehabilitation exercises and its effects on biomechanics on people who have had an anterior cruciate ligament reconstruction and healthy controls

Interventions

  • DEVICE Blood flow restriction

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-05-08
Est. Completion 2020-11-02
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT04635579

The ClinicalTrials.gov registry entry for NCT04635579 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Blood flow restriction is the first listed.

NCT04635579 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04635579 about?

NCT04635579 is a clinical study titled "Personalized Blood Flow Restriction for Anterior Cruciate Ligament Rehabilitation". This is a cross-sectional study on the use of personalized blood flow restriction during rehabilitation exercises and its effects on biomechanics on people who have had an anterior cruciate ligament reconstruction and healthy controls

What is the current status of trial NCT04635579?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-05-08. Estimated completion is 2020-11-02.

What interventions are being tested in trial NCT04635579?

The interventions under investigation include: Blood flow restriction (DEVICE).

Who is sponsoring clinical trial NCT04635579?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.